Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation

BACKGROUND: This study's primary objective was evaluation of the progression-free survival rate at 6 months (PFS-6) in patients with newly diagnosed glioblastoma without O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter hypermethylation postsurgically treated with enzastaurin before and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wick, Wolfgang, Steinbach, Joachim P., Platten, Michael, Hartmann, Christian, Wenz, Frederik, von Deimling, Andreas, Shei, Peipei, Moreau-Donnet, Valerie, Stoffregen, Clemens, Combs, Stephanie E.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3779043/
https://ncbi.nlm.nih.gov/pubmed/23911595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not100
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars